For Dr. Renato Martins, the theme that Seattle Cancer Care Alliance chose for the American Society of Clinical Oncology's annual meeting -- "tomorrow's treatments today” -- is more than just a catchy slogan. It’s his life’s work, illustrated by a clinical trial that was instrumental in changing the way that lung cancer patients are treated.
When Michael Rankin’s shoulder started hurting him two years ago, he didn’t hesitate to get it checked out. First he was referred to physical therapy. Then when the pain didn’t decrease, he got an X-ray, which eventually led to an MRI and biopsy that revealed the ultramarathon runner had stage 4 lung cancer.
More than a dozen Seattle Cancer Care Alliance (SCCA) and Fred Hutch physicians and researchers who are leaders in breast oncology will be at the San Antonio Breast Cancer Symposium December 4-8. The symposium provides the latest information on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease.
For many women with breast cancer, radiation is an integral part of their treatment plans.
But a landmark study, entitled Risk of Ischemic Heart Disease in Women after Radiotherapy, (Darby, et. al., published in the New England Journal of Medicine, 2013), has identified a troubling side effect of large radiation doses near the heart.